2021ESC共识文件《急性深静脉血栓的诊断和管理》解读  

Interpretation of the 2021 ESC Consensus Document “the Diagnosis and Management of Acute Deep Vein Thrombosis”

作　　者：尹琪楠 韩丽珠 边原[1] 黄雪飞 雷洋 宋玉洁 童荣生[1] YIN Qinan;HAN Lizhu;BIAN Yuan;HUANG Xuefei;LEI Yang;SONG Yujie;TONG Rongsheng(Personalized Drug Therapy Key Laboratory of Sichuan Province,Department of Pharmacy,Sichuan Academy of Medical Sciences,Sichuan Provincial People’s Hospital,Affiliated Hospital of University of Electronic Science and Technology of China,Chengdu 610072,China)

机构地区：[1]四川省医学科学院·四川省人民医院/电子科技大学附属医院药学部·个体化药物治疗四川省重点实验室,成都610072

出　　处：《医药导报》2022年第2期143-149,共7页Herald of Medicine

基　　金：国家重点研发计划(2020YFC2005500);个体化药物治疗四川省重点实验室开放课题(2021ZD01);四川省干部保健科研课题(川干研2021-226);四川省医学会静脉血栓栓塞症防治专项科研课题(2019HR02)。

摘　　要：2021年7月,欧洲心脏病学会(ESC)主动脉和外周血管疾病工作组以及肺循环与右心功能工作组发布第2版《急性深静脉血栓的诊断和管理》共识文件,作为对2017版共识文件的更新以及2019年ESC肺栓塞管理指南的配套文件,目的是提供静脉血栓栓塞性疾病患者的全面治疗管理,该文针对延长抗凝药物治疗的时间、癌症患者的管理、血栓后综合征的预防与处理、抗凝期间出血管理及妊娠期患者深静脉血栓治疗等方面进行全面解读,以期为临床应用提供参考。In July 2021,the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function published the Second consensus document on diagnosis and management of acute deep vein thrombosis,as an update to the 2017 consensus document and a companion document to the 2019 ESC Guidelines on the Management of Pulmonary Embolism(PE).The objective is to provide comprehensive therapeutic management of venous thromboembolic disease(VTE).In order to provide references for the clinical application,this paper gives a comprehensive interpretation for prolonging the time of anticoagulant therapy,management of cancer patients,prevention and management of post-thrombotic syndrome,management of bleeding during anticoagulation and treatment of deep vein thrombosis in pregnant patients.

关 键 词：急性深静脉血栓 血栓后综合征 抗凝治疗和管理 

分 类 号：R972[医药卫生—药品] R543.6[医药卫生—药学]